These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2511976)

  • 1. Campylobacter pylori, duodenal ulcer disease, and gastrin.
    Levi S; Dollery CT; Bloom SR; Calam J; Cox TM; Hodgson HJ; Losowsky MS; Pepys MB; Wright NA; Wrong OM
    BMJ; 1989 Oct; 299(6707):1093-4. PubMed ID: 2511976
    [No Abstract]   [Full Text] [Related]  

  • 2. Antral Helicobacter pylori, hypergastrinaemia, and duodenal ulcers: effect of eradicating the organism.
    Levi S; Beardshall K; Swift I; Foulkes W; Playford R; Ghosh P; Calam J
    BMJ; 1989 Dec; 299(6714):1504-5. PubMed ID: 2514864
    [No Abstract]   [Full Text] [Related]  

  • 3. Campylobacter pylori, gastrin, acid secretion, and duodenal ulcers.
    Levi S; Beardshall K; Desa LA; Calam J
    Lancet; 1989 Sep; 2(8663):613. PubMed ID: 2570297
    [No Abstract]   [Full Text] [Related]  

  • 4. Pathogenicity of Campylobacter pylori in the upper gastrointestinal tract--implications for modern therapy.
    Lambert JR; McLean AJ
    Med J Aust; 1989 Aug; 151(3):120-2. PubMed ID: 2755371
    [No Abstract]   [Full Text] [Related]  

  • 5. Campylobacter pylori and duodenal ulcers: the gastrin link.
    Levi S; Beardshall K; Haddad G; Playford R; Ghosh P; Calam J
    Lancet; 1989 May; 1(8648):1167-8. PubMed ID: 2566737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Campylobacter pylori, gastrin, and duodenal ulcer.
    Smith T; Vaira D; Ainley C; Holton J
    Lancet; 1989 Aug; 2(8659):389. PubMed ID: 2569578
    [No Abstract]   [Full Text] [Related]  

  • 7. Lowered gastrin and gastric acidity after eradication of Campylobacter pylori in duodenal ulcer.
    McColl KE; Fullarton GM; el Nujumi AM; Macdonald AM; Brown IL; Hilditch TE
    Lancet; 1989 Aug; 2(8661):499-500. PubMed ID: 2570202
    [No Abstract]   [Full Text] [Related]  

  • 8. Duodenal ulcer, Campylobacter pylori, and the "leaking roof" concept.
    Goodwin CS
    Lancet; 1988 Dec 24-31; 2(8626-8627):1467-9. PubMed ID: 2904580
    [No Abstract]   [Full Text] [Related]  

  • 9. Ablation of exaggerated meal-stimulated gastrin release in duodenal ulcer patients after clearance of Helicobacter (Campylobacter) pylori infection.
    Graham DY; Opekun A; Lew GM; Evans DJ; Klein PD; Evans DG
    Am J Gastroenterol; 1990 Apr; 85(4):394-8. PubMed ID: 2327380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Helicobacter pylori-related hypergastrinaemia is not due to elevated antral surface pH. Studies with antral alkalinisation.
    Chittajallu RS; Neithercut WD; Ardill JE; McColl KE
    Scand J Gastroenterol; 1992; 27(3):218-22. PubMed ID: 1502485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of eradication of Helicobacter pylori on serum pepsinogen I, gastrin, and insulin in duodenal ulcer patients: a 12-month follow-up study.
    Chen TS; Tsay SH; Chang FY; Lee SD
    Am J Gastroenterol; 1994 Sep; 89(9):1511-4. PubMed ID: 8079929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bismuth, Campylobacter, and ulcer relapse.
    de Wal J
    Lancet; 1988 Apr; 1(8589):824. PubMed ID: 2895340
    [No Abstract]   [Full Text] [Related]  

  • 13. Helicobacter pylori density on antral mucosa of patients with and without duodenal ulceration.
    Queiroz DM; Quintao JG; Rocha GA; Barbosa AJ; Mendes EN
    Gastroenterol Clin Biol; 1991; 15(6-7):558. PubMed ID: 1916140
    [No Abstract]   [Full Text] [Related]  

  • 14. Colloidal bismuth subcitrate (DE-NOL) and tinidazole healed duodenal ulceration with a low relapse rate due to elimination of Campylobacter pylori.
    Goodwin CS; Marshall BJ; Blackbourn SJ; Warren JR; Phillips M
    J Chemother; 1989 Jul; 1(4 Suppl):838-9. PubMed ID: 16312662
    [No Abstract]   [Full Text] [Related]  

  • 15. Colloidal bismuth in the treatment of duodenal ulceration: the benefit for the patient.
    Miller JP
    Scand J Gastroenterol Suppl; 1989; 157():16-20; discussion 21-2. PubMed ID: 2568684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Campylobacter pylori as a pathogenetic factor in duodenal ulcer: the case for.
    Graham DY
    Scand J Gastroenterol Suppl; 1989; 160():46-52. PubMed ID: 2814348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Campylobacter pylori and ulcer disease--a causal connection?
    Wormsley KG
    Scand J Gastroenterol Suppl; 1989; 160():53-8. PubMed ID: 2683023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. pH-dependent secretion of gastrin in duodenal ulcer disease: effect of suppressing Helicobacter pylori.
    Moss SF; Playford RJ; Ayesu K; Li SK; Calam J
    Digestion; 1992; 52(3-4):173-8. PubMed ID: 1459351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Campylobacter pylori. A new era in gastroduodenal disorders?
    Gill HH; Kalro RH; Desai HG
    J Assoc Physicians India; 1990 Feb; 38(2):147-50. PubMed ID: 2199425
    [No Abstract]   [Full Text] [Related]  

  • 20. Adjuvant antibiotic therapy in duodenal ulcers treated with colloidal bismuth subcitrate.
    O'Riordan T; Mathai E; Tobin E; McKenna D; Keane C; Sweeney E; O'Morain C
    Gut; 1990 Sep; 31(9):999-1002. PubMed ID: 2210469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.